Advanced Enzyme Technologies Ltd.
Snapshot View

275.70 +4.25 ▲1.6%

07 February 2023, 09:45:59 AM
Volume: 9,089

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.advancedenzymes.com
Market Cap 3,034.29 Cr.
Enterprise Value(EV) 2,866.60 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.58 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 31.63 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 104.11 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.61 Calculated using Price: 271.50
Dividend Yield 0.37 Period Ending 2022-03
No. of Shares Subscribed 11.18 Cr. 111,822,075 Shares
FaceValue 2
Company Profile
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.57%
1 Week
-1.76%
1 Month
-0.86%
3 Month
-3.50%
6 Month
-5.81%
1 Year
-14.18%
2 Year
-17.53%
5 Year
+5.43%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.70 27.31 31.32 25.06 18.34 18.82 17.61 16.77 12.04
Return on Capital Employed (%) 12.25 25.49 35.68 31.53 25.88 24.96 23.21 22.93 16.66
Return on Assets (%) 5.29 12.81 17.81 18.00 14.28 15.13 14.98 14.27 10.28

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 167 212 278 464 559 679 840 971 1,089 1,164
Non Curr. Liab. 94 64 56 32 47 35 44 49 59 56
Curr. Liab. 133 131 111 65 99 65 60 68 60 73
Minority Int. 4 4 5 21 23 26 28 62 52 52
Equity & Liab. 398 412 450 583 727 805 971 1,149 1,260 1,345
Non Curr. Assets 306 307 311 440 517 523 596 633 656 678
Curr. Assets 92 104 140 143 211 282 376 516 604 667
Misc. Exp. not W/O
Total Assets 398 412 450 583 727 805 971 1,149 1,260 1,345

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 239 223 294 329 391 420 444 502 529 525
Other Income 2 3 1 3 3 6 6 9 6 10
Total Income 241 226 295 332 394 425 450 511 536 536
Total Expenditure -138 -133 -156 -178 -227 -237 -241 -269 -327 -365
PBIDT 103 93 139 154 166 188 209 241 209 170
Interest -13 -9 -8 -4 -9 -5 -4 -3 -3 -2
Depreciation -10 -9 -9 -13 -18 -21 -26 -29 -35 -35
Taxation -7 -23 -41 -44 -45 -46 -46 -59 -47 -35
Exceptional Items -51 -4
PAT 21 52 77 93 94 116 133 151 124 98
Minority Interest -1 -1 -1 -1 -3 -5 -4 -5 -4 -2
Share Associate
Other Related Items
Consolidated Net Profit 20 51 76 92 90 111 129 146 120 96
Adjusted EPS 2 5 7 8 8 10 12 13 11 9

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 41 56 54 93 107 116 129 141 163 122
Cash Fr. Inv. -30 -9 -11 -5 -60 -78 -125 -45 -26 -25
Cash Fr. Finan. -5 -33 -36 -63 -65 -2 -43 -39 -26 -27
Net Change 7 13 6 26 -18 36 -39 58 111 70
Cash & Cash Eqvt 3 2 4 25 8 61 23 83 192 267

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 55.39 55.38 52.30 52.55 52.71 52.70 52.70 49.87 49.87
Public 44.61 44.62 47.70 47.45 47.29 47.30 47.30 50.13 50.13
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 03 Feb 2023
Loss of Share Certificates
Intimation regarding issuance of 'Letter of Confirmation' under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
Wed, 18 Jan 2023
Copy of Newspaper Publication
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), please find enclosed copy of the newspaper publication of Notice of Equity Shareholders of the Company regarding transfer of Unclaimed dividend/ Shares to the Investor Education & Protection Fund ( IEPF ), published in The Free Press Journal and Navshakti on January 17, 2023.Kindly take the same on record.
Tue, 17 Jan 2023
Copy of Newspaper Publication
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), please find enclosed copy of the newspaper publication of Notice of Equity Shareholders of the Company regarding transfer of Unclaimed dividend/ Shares to the Investor Education & Protection Fund ( IEPF ), published in The Free Press Journal and Navshakti on January 17, 2023.Kindly take the same on record.

Technical Scans View Details >>

Mon, 06 Feb 2023
Opening at Low Opening at Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
MFI Trending Down MFI Trending Down
CCI Oversold Zone CCI Oversold Zone
Fri, 03 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 245,571.93 1,015.15 -0.8%
Cipla Ltd. 83,115.65 1,028.05 -0.2%
Divi's Laboratories Ltd. 73,751.15 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. 72,438.62 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. 62,075.43 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,538.00 -0.4%
Zydus Lifesciences Ltd. 47,588.78 473.75 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.30 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-12 31.50 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.77 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.89 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 73.90 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.13 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.09 473.75 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.44 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-12 3.66 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.93 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.29 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.37 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.23 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.76 473.75 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.75 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.75 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.75 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.75 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,015.15 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,028.05 -0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,762.90 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,446.20 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,276.90 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.00 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.75 +0.8%

FAQ's On Advanced Enzyme Technologies Ltd.

What is Advanced Enzyme share price?

Can I buy Advanced Enzyme shares now?

What is the Dividend Yield of Advanced Enzyme?

What is the Market Cap of Advanced Enzyme?

What are the key metrics to analyse Advanced Enzyme?

What is the 52 Week High and Low of Advanced Enzyme?

What is the trend of Advanced Enzyme share price?